98 related articles for article (PubMed ID: 7905532)
1. Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs.
Shen YT; Zhang H; Vatner SF
J Pharmacol Exp Ther; 1994 Jan; 268(1):466-73. PubMed ID: 7905532
[TBL] [Abstract][Full Text] [Related]
2. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
Shen YT; Cervoni P; Claus T; Vatner SF
J Pharmacol Exp Ther; 1996 Sep; 278(3):1435-43. PubMed ID: 8819531
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and coronary vasodilative properties of a selective and full beta 1-adrenoceptor agonist, T-0509, in comparison with isoproterenol in anesthesized dogs.
Yamazaki J; Sugimoto T; Yabana H; Nagao T
J Cardiovasc Pharmacol; 1994 Aug; 24(2):209-15. PubMed ID: 7526052
[TBL] [Abstract][Full Text] [Related]
4. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
Dowell RT; Houdi AA
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
[TBL] [Abstract][Full Text] [Related]
5. Functional role of alpha-calcitonin gene-related peptide in the regulation of the cardiovascular system.
Shen YT; Pittman TJ; Buie PS; Bolduc DL; Kane SA; Koblan KS; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):551-8. PubMed ID: 11454916
[TBL] [Abstract][Full Text] [Related]
6. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
7. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
8. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation.
Osborn JL; DiBona GF; Thames MD
J Pharmacol Exp Ther; 1981 Feb; 216(2):265-9. PubMed ID: 6257884
[TBL] [Abstract][Full Text] [Related]
9. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
10. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
[TBL] [Abstract][Full Text] [Related]
12. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
Blaber LC; Burden DT; Eigenmann R; Gerold M
J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol.
Berl T; Cadnapaphornchai P; Harbottle JA; Schrier RW
J Clin Invest; 1974 Mar; 53(3):857-67. PubMed ID: 4812444
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
[TBL] [Abstract][Full Text] [Related]
16. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
Schiffelers SL; Blaak EE; Saris WH; van Baak MA
Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
[TBL] [Abstract][Full Text] [Related]
17. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
[TBL] [Abstract][Full Text] [Related]
18. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart.
Morisco C; Zebrowski DC; Vatner DE; Vatner SF; Sadoshima J
J Mol Cell Cardiol; 2001 Mar; 33(3):561-73. PubMed ID: 11181023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
